TLDR Sharps Technology stock jumped 96% after announcing a $400M raise for a Solana treasury The company signed a deal with Solana Foundation to purchase $50M in SOL tokens at a 15% discount Jambo co-founder Alice Zhang was appointed as Chief Investment Officer The fundraising attracted major crypto investors including ParaFi, Pantera, and CoinFund This [...] The post Sharps Technology Raises $400M for Solana Treasury Investment appeared first on Blockonomi.TLDR Sharps Technology stock jumped 96% after announcing a $400M raise for a Solana treasury The company signed a deal with Solana Foundation to purchase $50M in SOL tokens at a 15% discount Jambo co-founder Alice Zhang was appointed as Chief Investment Officer The fundraising attracted major crypto investors including ParaFi, Pantera, and CoinFund This [...] The post Sharps Technology Raises $400M for Solana Treasury Investment appeared first on Blockonomi.

Sharps Technology Raises $400M for Solana Treasury Investment

2025/08/26 19:37
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

TLDR

  • Sharps Technology stock jumped 96% after announcing a $400M raise for a Solana treasury
  • The company signed a deal with Solana Foundation to purchase $50M in SOL tokens at a 15% discount
  • Jambo co-founder Alice Zhang was appointed as Chief Investment Officer
  • The fundraising attracted major crypto investors including ParaFi, Pantera, and CoinFund
  • This follows a trend of health sector companies pivoting to crypto treasuries

Sharps Technology saw its stock price nearly double on Monday following the announcement of a $400 million fundraising round to create a Solana-focused digital asset treasury. The medical device maker’s shares jumped from $7.40 to reach an intraday high of $14.53 before settling at $12.01.

Source: Google FinanceSource: Google Finance

The Nasdaq-listed company signed a letter of intent with the Solana Foundation to purchase SOL tokens through a private investment in public equity (PIPE) transaction. This financing arrangement allows accredited investors to buy shares at a discount to current market prices.

Under the terms of the deal, Sharps will acquire $50 million worth of SOL tokens at a 15% discount to their 30-day average price. The transaction is expected to close around August 28, 2025.

The fundraising attracted several major crypto investment firms. Backers include ParaFi, Pantera, FalconX, CoinFund, and Arrington Capital. As part of the arrangement, shares were sold at $6.50 per unit with attached warrants that can be exercised at $9.75.

Investors may fund their allocations using either locked or unlocked SOL tokens. In return, they will receive pre-funded and stapled warrants, creating a structure that directly ties equity exposure to Solana.

The Rise of Crypto Treasuries

Sharps Technology is the latest public company to pivot toward accumulating cryptocurrencies. This growing trend has gained traction as firms seek to replicate the success of Michael Saylor’s Strategy, which has become the largest corporate owner of Bitcoin with holdings worth over $70 billion.

These companies, often called digital asset treasuries (DATs), raise money in capital markets to purchase cryptocurrencies. They provide investors with indirect exposure to crypto assets through traditional stock investments.

Several other companies have already adopted this approach for Solana. SOL Strategies, DeFi Development, and Upexi are among the listed firms accumulating SOL tokens.

The Solana ecosystem may soon see more major players. Reports indicate that Galaxy Digital, Multicoin Capital, and Jump Crypto are seeking to raise $1 billion to build a treasury focused on SOL. They plan to buy out a listed firm and have hired Cantor Fitzgerald as the lead banker.

Healthcare Companies Embracing Crypto

The crypto treasury model has recently gained popularity in the health sector. Several small and mid-cap healthcare firms have added digital assets to their balance sheets to diversify and attract investor attention.

In November 2024, Hoth Therapeutics, a New York-based biopharma company, allocated $1 million to Bitcoin as a treasury asset. They framed the move as a hedge against inflation.

March saw Nasdaq-listed Atai Life Sciences, which develops psychedelic-based mental health treatments, purchase $5 million in Bitcoin. Founder Christian Angermayer argued that drug development requires substantial cash and regulatory approvals can take more than a decade.

In July, 180 Life Sciences, a biotech working on anti-inflammatory therapeutics, rebranded as ETHZilla. After its stock had fallen 99%, the company announced plans to build a $425 million Ethereum treasury.

As part of its strategic shift, Sharps Technology announced two key appointments from the Solana ecosystem. Jambo co-founder Alice Zhang will join as Chief Investment Officer to lead the company’s new direction. Additionally, James Zhang will serve as a strategic adviser.

The company plans to allocate the raised funds primarily toward acquiring SOL, the native token of the Solana blockchain. This move represents what could become the largest corporate digital asset treasury focused on Solana.

DATs typically trade at a premium relative to their underlying holdings. However, they may face pressure during market downturns when this premium contracts, potentially limiting their ability to raise funds for additional purchases.

Wall Street firm Charles Schwab recently cautioned about this trend. In an educational video, the firm warned that companies “putting large chunks of cash in a historically volatile asset that isn’t tied to their core business has raised a red flag or two.”

The post Sharps Technology Raises $400M for Solana Treasury Investment appeared first on Blockonomi.

Market Opportunity
Solana Logo
Solana Price(SOL)
$86.7
$86.7$86.7
+1.53%
USD
Solana (SOL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

UNI Price Prediction: Testing $4.17 Upper Band Resistance, Targets $4.50 by April 2026

UNI Price Prediction: Testing $4.17 Upper Band Resistance, Targets $4.50 by April 2026

Uniswap trades at $3.88 with neutral RSI at 51.98. Technical analysis suggests potential breakout to $4.17 upper Bollinger Band, with bullish targets reaching $
Share
BlockChain News2026/03/12 17:21
Speed, Cost, and Intelligence: How Kie.ai’s Gemini 3 Flash API Balances Performance and Budget for Developers

Speed, Cost, and Intelligence: How Kie.ai’s Gemini 3 Flash API Balances Performance and Budget for Developers

Integrating AI into applications is a balancing act between performance, cost, and intelligence. Traditionally, high-performance AI models come with steep costs
Share
Techbullion2026/03/12 16:55
Cash Flow Valuation HyperLiquid: Could $HYPE Reach $385 in Five Years?

Cash Flow Valuation HyperLiquid: Could $HYPE Reach $385 in Five Years?

Author: G3ronimo Compiled by: TechFlow HyperLiquid has grown into a mature crypto-native exchange, with the majority of its net fees programmatically distributed directly to token holders through an "Assistance Fund" (AF). This design makes $HYPE one of the few tokens capable of being valued based on cash flow. To date, most valuations of HyperLiquid have relied on traditional multiples, comparing it to established financial platforms like Coinbase and Robinhood, using EBITDA or revenue multiples as a reference. Unlike traditional corporate stocks, where management typically retains and reinvests earnings at their discretion, HyperLiquid systematically returns 93% of transaction fees directly to token holders through a support fund. This model creates predictable and quantifiable cash flows, making it well-suited for detailed discounted cash flow (DCF) analysis rather than static multiple comparisons. Our methodology begins by determining $HYPE's cost of capital. We then invert the current market price to determine the market-implied future earnings. Finally, we apply growth projections to these earnings streams and compare the resulting intrinsic value to today's market price, revealing the valuation gap between current pricing and fundamental value. Why choose discounted cash flow (DCF) over a multiple? While other valuation methods compare HyperLiquid to Coinbase and Robinhood via EBITDA multiples, these methods have the following limitations: The difference between the corporate and token structures: Coinbase and Robinhood are corporate stocks, whose capital allocation is guided by the board of directors, and profits are retained and reinvested by management; while HyperLiquid systematically returns 93% of trading fees directly to token holders through a relief fund. Direct Cash Flow: HyperLiquid's design generates predictable cash flows that are well-suited to DCF models, rather than static multiples. Growth and risk characteristics: DCFs are able to explicitly model different growth scenarios and risk adjustments, whereas multiples may not adequately capture growth and risk dynamics. Determining an appropriate discount rate To determine our cost of equity, we start with reference data from the public market and adjust for cryptocurrency-specific risks: Cost of equity (r) ≈ Risk-free rate + β × Market risk premium + Crypto/illiquidity premium Beta Analysis Based on regression analysis with the S&P 500: Robinhood (HOOD): Beta of 2.5, implied cost of equity of 15.6%; Coinbase (COIN): Beta of 2.0, implied cost of equity of 13.6%; HyperLiquid (HYPE): Beta is 1.38 and the implied cost of equity is 10.5%. At first glance, $HYPE appears to have a lower beta, and therefore a lower cost of equity than Robinhood and Coinbase. However, the R² value reveals an important limitation: HOOD: The S&P 500 explains 50% of its returns; COIN: The S&P 500 explains 34% of its return; HYPE: The S&P 500 only explains 5% of its returns. $HYPE’s low R² suggests that traditional stock market factors are insufficient to explain its price fluctuations, and crypto-native risk factors need to be considered. risk assessment Despite $HYPE’s lower beta, we still adjust its discount rate from 10.5% to 13% (which is more conservative compared to COIN’s 13.6% and HOOD’s 15.6%) for the following reasons: Lower governance risk: Direct programmatic distribution of 93% of fees reduces concerns about corporate governance. In contrast, COIN and HOOD do not return any earnings to shareholders, and their capital allocation is determined by management. Higher Market Risk: $HYPE is a crypto-native asset and is subject to additional regulatory and technological uncertainties. Liquidity considerations: Token markets are generally less liquid than established stock markets. Get the Market Implied Price (MIP) Using our 13% discount rate, we can reverse engineer the market’s implied earnings expectations at the current $HYPE token price of approximately $54: Current market expectations: 2025: Total revenue of $700 million 2026: Total revenue of $1.4 billion Terminal growth: 3% annual growth thereafter These assumptions yield an intrinsic value of approximately $54, which is consistent with current market prices. This suggests that the market is pricing in modest growth based on current fee levels. At this point we need to ask a question: Does the market-implied price (MIP) reflect future cash flows? Alternative growth scenarios @Keisan_Crypto presents an attractive 2-year and 5-year bull market scenario. Original tweet link: Click here Two-year bull market forecast According to @Keisan_Crypto’s analysis, if HyperLiquid achieves the following goals: Annualized fees: $3.6 billion Aid fund income: $3.35 billion (93% of fees) Result: HYPE's intrinsic value is $128 (140% undervalued at current price) Related links Five-year bull market scenario Under a five-year bull market scenario (link), he predicts that transaction fees will reach $10 billion annually, with $9.3 billion accruing to $HYPE. He assumes HyperLiquid's global market share will grow from its current 5% to 50% by 2030. Even if it doesn't reach 50% market share, these figures are still achievable with a smaller market share as global trading volumes continue to grow. Five-year bull market forecast Annualized fees: $10 billion Aid fund income: $9.3 billion Result: HYPE's intrinsic value is $385 (600% undervalued at current price) Related links While this valuation is lower than Keisan's $1,000 target, the difference stems from our assumption of normalized earnings growth at 3% annually thereafter, while Keisan's model uses a cash flow multiple. We believe using cash flow multiples to project long-term value is problematic, as market multiples are volatile and can vary significantly over time. Furthermore, the multiples themselves incorporate earnings growth assumptions, while using the same cash flow multiple five years from now as one or two years later implies that growth levels from 2030 onward will be consistent with those in 2026/2027. Therefore, the multiples are more appropriate for short-term asset pricing. However, regardless of which model is used, $HYPE remains undervalued; this is a subtle difference. Additional Value Driver: USDH Under the Native Market model, USDH will use 50% of its stablecoin revenue for buybacks similar to a bailout fund. As a result, $HYPE can increase its free cash flow by $100 million (50% of $200 million) annually. Looking ahead five years, if USDH's market capitalization reaches $25 billion (currently still one-third of USDC's, and an even smaller portion of the total stablecoin market five years from now), its annual revenue could reach $1 billion. Following the same 50% distribution model, this would generate an additional $500 million in free cash flow per year for the aid fund. This would value each token at over $400. Excluding Value Drivers: HIP-3 and HyperEVM This DCF analysis intentionally excludes two important potential value drivers that are not amenable to cash flow modeling. Clearly, these would provide additional incremental value and could therefore be evaluated separately using different valuation methodologies and then added to this valuation. Summarize Our DCF analysis indicates that if HyperLiquid can maintain its growth trajectory and market position, the $HYPE token is significantly undervalued. The token's unique feature of programmatic fee distribution makes it particularly suitable for cash flow-based valuation methodologies. Methodological Notes This analysis builds on research by @Keisan_Crypto and @GLC_Research. The DCF model is open source and can be modified at the following link: https://valypto.xyz/project/hyperliquid/oNQraQIg Market data and forecasts are subject to change, and models should be updated promptly based on the latest information.
Share
PANews2025/09/19 08:00